Cargando…
Data on alteration of hormone and growth factor receptor profiles over progressive passages of breast cancer cell lines representing different clinical subtypes
Human breast cancers are a highly heterogeneous group of tumours consisting of several molecular subtypes with a variable profile of hormone, growth factor receptors and cytokeratins [1]. Here, the data shows immunofluorescence profiling of four different cell lines belonging to distinct clinical su...
Autores principales: | Nair, Madhumathy G., Desai, Krisha, Prabhu, Jyothi S., Hari, P.S., Remacle, Jose, Sridhar, T.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961495/ https://www.ncbi.nlm.nih.gov/pubmed/27508248 http://dx.doi.org/10.1016/j.dib.2016.07.001 |
Ejemplares similares
-
High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis
por: Nair, Madhumathy G, et al.
Publicado: (2021) -
miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis
por: Nair, Madhumathy G, et al.
Publicado: (2020) -
miR-18a Mediates Immune Evasion in ER-Positive Breast Cancer through Wnt Signaling
por: Nair, Madhumathy G., et al.
Publicado: (2022) -
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors
por: Prabhu, Jyothi S., et al.
Publicado: (2014) -
Metabolomic and quality data for early and late passages of an antibody-producing industrial CHO cell line
por: Sowa, Steven W., et al.
Publicado: (2020)